Biomarkers of heterogeneity in type 1 diabetes: an integrated approach to clinical and metabolic phenotyping of individuals with established Type 1 diabetes - Biomarkers in type 1 diabetes

Diabeter0 个研究点目标入组 600 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•1. Type 1 diabetes determined by either autoantibodies or based on clinical and historical data, or both
•2. At least 5 years of type 1 diabetes
•3. Minimum age 16 years
•4. Treated for type 1 diabetes at a diabetes center
•5. Given informed consent by subject

•1. Non-type 1 diabetes
•2. Patients with duration of type 1 diabetes below 5 years
•3. Patients under the age of 16 years
•4. Pregnancy or breastfeeding, until 3 months (12 weeks) after childbirth or breastfeeding
•5. On experimental medication or participating in other studies with conflicting goals and schedules
•6. Diseases or conditions that the investigator/physician believes to be a contraindication to participate
•7. Unwilling to be informed on incidental findings

发起方

Diabeter